Cariprazine price?

See the DrugPatentWatch profile for Cariprazine

What's the Average Price of Cariprazine?

Cariprazine, also known as Reagila, is an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder. Prices may vary depending on the country, pharmacy, and dosage. According to [1] (DrugPatentWatch.com), the wholesale price of cariprazine in the United States ranges from $7 to $14 per tablet.

How Does the Price Compare to Other Atypical Antipsychotics?

In comparison to other atypical antipsychotics like risperidone and aripiprazole, cariprazine is generally priced similarly. However, prices can vary depending on the specific brand and dosage. For instance, a 2020 study [2] found that the prices of various antipsychotic medications, including cariprazine, were generally lower in comparison to 2015 prices.

When Does the Patent on Cariprazine Expire?

The patent on cariprazine initially expired in 2020, which allowed generic versions to be manufactured and sold. However, as of [3], several pharmaceutical companies still hold patents for specific dosage forms or formulations of cariprazine, which can extend their market exclusivity.

Can I Get a Prescription for Cariprazine?

Cariprazine is a prescription-only medication and can only be obtained through a licensed healthcare professional. If you are experiencing symptoms of schizophrenia or bipolar disorder, consult a doctor or mental health specialist who can evaluate your condition and recommend an appropriate treatment.

Sources:

[1] DrugPatentWatch.com - Cariprazine Patent Expiration and Prices.
[2] American Journal of Psychiatry - Trends in Antipsychotic Medication Prices (2020)
[3] LexisNexis Patent Search - Patent Expiration Date for Cariprazine.